Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer
활용도 Analysis
논문 Analysis
연구자 Analysis
'
Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer' 의 참고문헌
Tumors and fibrinogen : the role of fibrinogen as an extracellular matrix protein
The prognostic value of pretreatment of systemic inflammatory responses in patients with urothelial carcinoma undergoing radical cystectomy
The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer
Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer
Serum albumin level at diagnosis of diffuse large B-cell lymphoma : an important simple prognostic factor
Prognostic value of the fibrinogen/albumin ratio(FAR)in patients with operable soft tissue sarcoma
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status
Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors : a systematic review and meta-analysis
Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors : a systematic review and metaanalysis of 66 cohort studies
Prognostic role of albumin, bilirubin, and ALBI scores : analysis of 1000 patients with hepatocellular carcinoma undergoing radioembolization
Preoperative neutrophil-lymphocyte and lymphocyte-monocyte ratios reflect immune cell population rearrangement in resectable pancreatic cancer
Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma : a study within the National Cancer Institute Cohort Consortium
Pre-operative serum albumin is associated with postoperative complication rate and overall survival in patients with epithelial ovarian cancer undergoing cytoreductive surgery
Outcomes following resection of pancreatic cancer
Neutrophils in cancer : neutral no more
Hyperfibrinogen is associated with the systemic inflammatory response and predicts poor prognosis in advanced pancreatic cancer
Hallmarks of cancer : the next generation
Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma
Exfoliated black phosphorus promotes in vitro bone regeneration and suppresses osteosarcoma progression through cancer-related inflammation inhibition
Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen : a phase IIb randomized, placebocontrolled trial
Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer
Clinical and prognostic significance of preoperative plasma hyperfibrinogenemia in gallbladder cancer patients following surgical resection : a retrospective and in vitro study
Cellular determinants and therapeutic implications of inflammation in pancreatic cancer
Cancer immunity : lessons from infectious diseases
Albuminto-fibrinogen ratio as a promising biomarker to predict clinical outcome of non-small cell lung cancer individuals
Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases
A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma : the Fibrinogen/Albumin Ratio
'
Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer'
의 유사주제(
